CVE-2021-26726 Vulnerability Details

  /     /     /  

CVE-2021-26726 Metadata Quick Info

CVE Published: 16/02/2022 | CVE Updated: 17/09/2024 | CVE Year: 2021
Source: Nozomi | Vendor: Valmet DNA | Product: Valmet DNA
Status : PUBLISHED

---

CVE-2021-26726 Description

A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions from Collection 2012 until Collection 2021.

Metrics

CVSS Version: 3.1 | Base Score: 8.8 HIGH
Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

l➤ Exploitability Metrics:
    Attack Vector (AV)* ADJACENT_NETWORK
    Attack Complexity (AC)* LOW
    Privileges Required (PR)* NONE
    User Interaction (UI)* NONE
    Scope (S)* UNCHANGED

l➤ Impact Metrics:
    Confidentiality Impact (C)* HIGH
    Integrity Impact (I)* HIGH
    Availability Impact (A)* HIGH

Weakness Enumeration (CWE)

CWE-ID: CWE-305
CWE Name: CWE-305 Authentication Bypass by Primary Weakness
Source: Valmet DNA

Common Attack Pattern Enumeration and Classification (CAPEC)

CAPEC-ID:
CAPEC Description:


Source: NVD (National Vulnerability Database).